Hemophilia Treatment Options

Hemophilia Education Series
1 ACPE 1 ANCC Contact Hours 1 AMA PRA Category 1 Credit(s)
Launch Date:
July 29, 2015
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

Physcians, Nurses, Pharmacists

Relevant Terms:


Michelle Witkop, DNP, FNP-BC

Michelle Witkop, DNP, FNP-BC
Doctor of Nursing Practice
Bleeding Disorders Nurse Practitioner
Northern Regional Bleeding Disorders Center
1105 Sixth Street
Traverse City, MI

Dr. Witkop is a doctoral prepared nurse practitioner practicing at the Northern Regional Bleeding Disorders Center in Traverse City MI.  She is the Chair of the National Hemophilia Foundation Nursing Work Group and the Co-Chair of NHF’s Annual Meeting for 2014 and 2015. As well as being a charter member of the American Thrombosis & Hemostasis Network’s National Hemophilia Program Coordination Center Advisory Committee, Dr.  Witkop is an ATHN/HRSA Demonstration Project of National Significance Grantee with the project, “Evaluating a Nurse Practitioner Medically Lead Hemophilia Treatment Center in Comparison to a Physician Medically Lead Hemophilia Treatment Center”.
Dr. Witkop’s background includes extensive experience in pain management including chronic pain and palliative care. She has been the principal investigator for several hemophilia pain research studies including the national Pain Study and the IMPACT Quality of Life Studies. She has published multiple articles on that research as well as lectured extensively on the topic.

Sue Gerghty, RN MBA

Sue Gerghty, RN, MBA
Nurse Planner
SolutionSight Inc.
2191 Avalon Drive
Buffalo Grove, IL

Ms. Geraghty has an Associate of Arts degree in nursing from Lander College in 1977, a Bachelor of Science degree in Nursing in 1980 from University of North Carolina at Charlotte and a Masters in Business (MBA) from University of Colorado Denver in 1990. She worked as Nurse Coordinator at the University of Colorado Denver Hemophilia and Thrombosis Center for 25 years where she retired in2013. Currently she is working as an independent consultant in the areas of hemophilia and health care education. Prior to working at the HTC, Ms. Geraghty worked in orthopaedics where she was initially introduced to patients with hemophilia. She is certified as an Orthopaedic Nurse Clinician through the National Association of Orthopaedic Nurses where she is still an active member. During her time as nurse coordinator at the Hemophilia Treatment Center, she has sat on a number of national committees including the Nursing working Group for the National Hemophilia Foundation. She has spoken locally, nationally and internationally and has been published in many peer reviewed journals. Her areas of interest within the hemophilia community include the adult patient with bleeding disorders, patients with inhibitors and orthopaedic issues.
1. Discuss the history and background of hemophilia treatment
2. Explain treatment and prevention of bleeding
3. Describe current treatment options in hemophilia
4. Review supportive therapies

If you have questions about this CME activity, please contact AKH Inc. at service@akhcme.com or SolutionSight Inc. at contactus@solutionsight.com.
CME credit provided by AKH Inc., Advancing Knowledge in Healthcare.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and SolutionSight, Inc. AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.
AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Assistants
NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.
CE credit provided by SolutionSight, Inc.

SolutionSight, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is awarded 1 contact hour.


SolutionSight, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Solutionsight Inc. approves this knowledge-based activity for 1 contact hour (0.1 CEUs).
UAN 0450-9999-15-002-H01-P. Initial Release Date: July 29, 2015.
Activity is jointly-provided by AKH Inc., Advancing Knowledge in Healthcare and SolutionSight, Inc.
Name Relationship Commercial Interest
Michelle Witkop, DNP, FNP-BC Other Research Grant Pfizer, Inc.
  Consultant Baxter BioScience, NovoNordisk, Pfizer, Inc - Advisory Panels and
  Speakers Bureau Novo Nordisk
SolutionSight, Inc. Staff and Planners N/A Nothing to dislose
AKH Inc. Staff and Planners N/A Nothing to dislose
Commercial Support
This activity is supported by an educational grant from Baxter Healthcare Corporation.
It is the policy of AKH Inc. and SolutionSight, Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME/CE expectations; referral to National Author Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other author for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review. 
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Supported Browsers:
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6+ for Mac OSX 10.7 and above

For video playback, install the latest version of Flash or Quicktime.